Anna Mowry, CFO and Treasurer at Nautilus Biotechnology, Inc. (NAUT), bought 17,500 shares at $7.71 ($135K) on 2021-08-12, disclosed to the SEC on 2021-08-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| NAUT | BUY | 2022-06-28 | $15K | — | Filing → |
| NAUT | BUY | 2021-11-24 | $69K | — | Filing → |